Get started
Author

Marta Usó

Observed names: M. Uso, M. Usó, Usó M, Usó,Marta
OpenAlex ID: A5036255313
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
2016 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Oncotarget · 44
PDF
miRNA Detection Methods and Clinical Implications in Lung Cancer
2014 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Future Oncology · 39
MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
2017 · Sandra Gallach, Eloisa Jantus-Lewintre, et al. · Oncotarget · 37
PDF
A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer
2013 · Elena Sanmartín, Rafael Sirera, et al. · Annals of Surgical Oncology · 31
Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients
2016 · Marta Usó, Eloísa Jantus-Lewintre, et al. · OncoImmunology · 18
PDF
Ratios between VEGF ligands and receptors in tumor and stroma have impact on the outcome in resectable NSCLC.
2013 · Eloisa Jantus-Lewintre, Marta Usó, et al. · Journal of Clinical Oncology · 2
Immune Checkpoints Score and CD8+ T Cells Infiltration Are Independent Prognostic Biomarkers in Resected Nsclc
2015 · M. Usó, E. Jantus-Lewintre, et al. · Annals of Oncology · 1
PDF
MiRNA profiling by NGS in resectable non-small cell lung cancer: Prognostic implications.
2014 · Sandra Gallach, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology · 1
Tumor expression levels of CSC markers in resectable non-small cell lung cancer.
2014 · Silvia Calabuig, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology · 1
Analysis of the prognostic impact of Treg-related genes in tumor and stroma in resectable NSCLC.
2013 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology · 1
Association of Foxp3 expression with prognosis in resected non-small cell lung cancer (NSCLC).
2011 · M. Usó, E. Jantus-Lewintre, et al. · Journal of Clinical Oncology · 1
Abstract 4330: Immune checkpoint expression score is an independent prognostic biomarker in resectable non-small cell lung cancer
2015 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Cancer Research
Analysis of the prognostic value of the tumor immunologic profile in resectable NSCLC.
2015 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology
133 Analysis of immune microenvironment in resectable NSCLC: Prognostic value of regulatory and conventional T cell markers proportion
2014 · M. Uso, R. Sirera, et al. · European Journal of Cancer
122 Analysis of immune-response markers in resectable NSCLC
2014 · M. Usó, E. Jantus-Lewintre, et al. · European Journal of Cancer
Prognostic Impact of Vegfa in Resectable Non-Small-Cell Lung Cancer
2014 · S. Calabuig Fariñas, E. Jantus-Lewintre, et al. · Annals of Oncology
Prognostic Impact of Immune Microenvironment Markers in Tumor and Stroma in Resectable Nsclc
2014 · M. Usó, J.J. Pérez, et al. · Annals of Oncology
Prognostic role of immune checkpoint-related genes in resectable lung adenocarcinomas.
2014 · Marta Usó, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology
Prognostic role of FOXP3/CD4 ratio in resectable NSCLC.
2012 · Marta Usó, Rafael Sirera, et al. · Journal of Clinical Oncology
Prognostic value of “angiogenic” risk score in early-stage NSCLC.
2012 · Elena Sanmartin, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology
miRNA profiling in resectable NSCLC by multiplex next-generation sequencing.
2012 · Sandra Gallach, Eloisa Jantus-Lewintre, et al. · Journal of Clinical Oncology
1096 POSTER Expression of Treg Associated Markers Have Prognostic Implications in Early-stage NSCLC
2011 · E. Jantus-Leintre, M. Usó, et al. · European Journal of Cancer
9130 POSTER The Prognostic Role of Myeloid-derived Suppressor Cells Related Markers in Peripheral Blood From Advanced Non-small Cell Lung Cancer Patients
2011 · R. Sirera, E. Jantus-Lewintre, et al. · European Journal of Cancer
9131 POSTER Relative Expression of Regulatory T-lymphocyte Associated Markers Inperipheral Blood Samples From Advanced NSCLC – Analysis of the Prognostic Role
2011 · R. Sirera, E. Jantus-Lewintre, et al. · European Journal of Cancer
The surfactant protein B (SFTPB) as a surrogate of circulating tumor cells (CTC) with prognostic value in advanced-stage NSCLC.
2011 · R. Sirera, E. Jantus-Lewintre, et al. · Journal of Clinical Oncology
Works count: 29
Citation count: 184
H-index: 6
I10-index: 5
Year
Topic
Type